• Community
  • Blog
  • Join IBI
  • Contact
  • Login
Integrated Benefits Institute
Integrated Benefits Institute

Or, try our Advanced Search.

  • Tools & Analysis
    • Benchmarking
    • Full Cost Estimator (FCE)
    • Snapshot
    • Interactive COVID-19 Map
    • Medication Adherence Calculator
    • Disability Diagnosis Analyzer
  • Research & Resources
    • Research Publications
    • Peer Perspectives
      • Employer Perspectives
      • Market Perspectives
    • Leave Benchmarking
  • Networking & Events
    • Events Calendar
    • Rethinking Benefit Design and Workplace Policy
    • IBI/Conference Board Health & Productivity Forum
  • Membership
    • Employers
    • Suppliers
    • Member Sign-Up
  • About
    • In The News
    • IBI Newsletter
    • IBI Team
    • Board of Directors
  • Tools & Analysis
    • Benchmarking
    • Full Cost Estimator (FCE)
    • Snapshot
    • New! Interactive COVID-19 Map
    • Medication Adherence Calculator
    • Disability Diagnosis Analyzer
  • Research & Resources
    • Research Publications
    • Peer Perspectives
      • Employer Perspectives
      • Market Perspectives
    • IBI Leave Management Benchmarking Series
    • Chronic Conditions Impact Reports
  • Networking & Events
    • Events Calendar
    • IBI/Conference Board Health and Productivity Forum
  • Membership
    • Employers
    • Suppliers
    • Member Sign-up
  • About
    • In the News
    • IBI Newsletters
    • Inside IBI
    • Contact
pbgh
IBI_logo_222px

Biosimilars: The Next Frontier

 

 

Biologics have grown to be a vital component of modern medicine, bringing life-saving treatments to patients suffering from deadly diseases and providing remedies and solutions for those managing chronic conditions.

With many of the biologics facing patent expiration in the upcoming years, the biosimilar market has the foundation for future growth. This potentially presents unique opportunities to reduce healthcare costs and expand access to more affordable treatments for patients. Biosimilars products may open a new frontier to improving adherence and health outcomes—but to get there, research and healthy competition to fuel market growth is needed.

By attending this event, participants can expect to finish the two-part seminar with an understanding of the potential for biosimilars and the importance of promoting their use in order to sustain this necessary competitive force. Topics will cover:

  • What are biosimilars?
  • The changing marketplace
  • Alignment of incentives among purchaser, providers and plans
  • Optimizing access and affordability through benefit design

For PBGH & IBI members, please register using the code you received via email by first selecting the register button, then clicking the link to enter promo code.

_______
_______

Event Recap
View a recap of the event.

Event Agenda
View the full program and speakers for the event.

Event Booklet
Event booklet containing agenda, speaker bios and event participants.


Event Sponsors

 

Platinum Sponsor

 

Pfizer-2020
RESOURCES BELOW


Employer Check List
Employer Presentation
Additional Information

 

 

Gold Sponsors

 

Genentech-2020
Resources
Janssen-2020-400x83
Merck-2020
Resources

Event Speakers

 

 

Sameer Awsare, MD, Associate Executive Director, The Permanente Medical Group

BIO
Awsare_011_V2TD
Presentation slides

Ladd Carman, BPharm,
Director, Specialty
Pharmacy Services, Costco

BIO
Ladd-C.-headshot
Presentation slides

Bill Dinger, MBA, CPA
Director, Healthcare Innovation
& Labor, The Walt Disney
Company

BIO
Bill.Photo_
Presentation slides

Brian Gifford, PhD,
Director, Research and
Analytics, Integrated Benefits
Institute

BIO
BG-headshot-1
Presentation slides

Lucy Langer, MD
Medical Director, Practice Solutions,
The US Oncology Network

BIO
Langer_Lucy_med_horiz_300dpi
Presentation slides

Melissa Mantong, PharmD,
MS, FCSHP, Pharmaceutical
Consultant II, CalPERS Health
Policy and Benefits Branch
Clinical Policy and Programs
Section

BIO
melissa-mantong-headshot-2019.1
Presentation slides

Megan McIntyre, PharmD,
MHA, Pharmacist Advisor,
Benefits & Revenue Cycle,
Virginia Mason Medical Center

BIO
McIntyre_Megan
Presentation slides

Rob Paczkowski, CEBS
Senior Director, Global
Benefits, eBay

BIO
Paczkowski

Juliana Reed, MS,
Vice President, Global Corporate Affairs Lead,
Pfizer

BIO
Juliana-Reed
Presentation slides

Megan McIntyre, PharmD,
MHA, Pharmacist Advisor,
Benefits & Revenue Cycle,
Virginia Mason Medical Center

BIO
Sundar-Photo

Rob Paczkowski, CEBS
Senior Director, Global
Benefits, eBay

BIO
Tsai
Presentation slides

Juliana Reed, MS,
Vice President, Global Corporate Affairs Lead,
Pfizer

BIO
winegarden
Presentation slides

CONTACT

Integrated Benefits Institute 
1901 Harrison Street, Suite 1100 Oakland, CA 94612

  • 415-222-7280

  • info@ibiweb.org

NAVIGATE

  • Tools & Analysis
  • Research & Resources
  • Networking & Events
  • Membership
  • About
  • Contact

MEMBERSHIP

What kind of member are you? Does your company/organization sell health & productivity products or services?


YES NO

© 2023 Integrated Benefits Institute | All Rights Reserved | Disclaimer | Privacy Policy | Login